Recent Quotes (30 days)

You have no recent quotes
chg | %

Takeda Pharmaceutical Co Ltd news

   Watch this stock
Showing stories 1 - 10 of about 123   

Articles published

4502 5,248.00 +6.00 (0.11%)
price chart
Takeda Pharmaceutical to transfer Japan consumer healthcare business to subsidiary
TOKYO-LISTED Takeda Pharmaceutical Company Limited will transfer its Japan consumer healthcare business unit to Takeda Consumer Healthcare Company Limited (TCHC), its wholly owned subsidiary.
Takeda Splits Off Its Consumer Healthcare Biz  PharmaLive (press release) (subscription)
Takeda Completes Acquisition of ARIAD Pharmaceuticals, Inc.
CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502) (“Takeda”) today announced the completion of its acquisition of ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) (“ARIAD”) for $24.00 per share in ...
Prosetta Biosciences, Inc. And Takeda Pharmaceutical Company Limited, Enter ...
SAN FRANCISCO, May 2, 2016 /PRNewswire/ -- Prosetta Biosciences, Inc. (the "Company," or "Prosetta"), today announced that it has entered into a Feasibility and First Right of Negotiation Agreement (the "Agreement") with Takeda Pharmaceutical ...
Exelixis, Inc. (NASDAQ:EXEL) And Takeda Pharmaceutical Co Ltd (ADR)(OTCMKTS ...
Takeda Pharmaceutical Co Ltd (ADR)(OTCMKTS:TKPYY) and Exelixis, Inc. (NASDAQ:EXEL) has finalized an exclusive licensing deal for the commercialization and clinical development of cabozantinib in Japan.
Scorching Hot Biotech Stocks Tape: Exelixis, Inc. (EXEL), Gilead Sciences ...  The Independent Republic
Morning Top Movers: Exelixis, Inc. (NASDAQ:EXEL), Textron Inc. (NYSE:TXT)  Benchmark Monitor
BRIEF-Takeda Pharmaceutical & Ovid Therapeutics announces clinical development ...
Jan 18 Takeda Pharmaceutical Co Ltd: * Takeda and Ovid Therapeutics announce innovative clinical development, commercialization collaboration for TAK-935 in rare pediatric epilepsies.
Takeda and Ovid Therapeutics Announce Innovative Clinical Development and ...  Business Wire (press release)
Takeda teams up with Ovid Therapeutics to develop epilepsy drug  Seeking Alpha
Takeda to Invest More Than 100 Million Euros in Dengue Vaccine Manufacturing ...
KONSTANZ, Germany & OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TOKYO:4502) (“Takeda”) today announced that it will invest more than 100 Million Euros to build a new manufacturing plant for its dengue vaccine ...
Valeant: Forget About Acquisition. Takeda Has Bought ARIAD
Takeda was planning an acquisition; however, instead of buying Valeant's Salix, the Japanese gastro-pharma bought ARIAD (NASDAQ:ARIA) - an oncological business with a strong pipeline and significant pricing power.
Takeda and PRA Health Sciences Announce Transformational Clinical Development ...
OSAKA, Japan & RALEIGH, N.C.--(BUSINESS WIRE)--PRA Health Sciences, Inc. (NASDAQ: PRAH) and Takeda Pharmaceutical Company Limited (TSE: 4502) announced today that the companies have entered into a new partnership agreement under ...
Raleigh's PRA Health signs 'transformational' deal with Takeda  Triangle Business Journal
Takeda acquisition spree may continue
Japan's Takeda Pharmaceutical (OTCPK:TKPYY) is willing to bolster its drug portfolio through fresh acquisitions after agreeing on Monday to buy Ariad Pharmaceuticals for $5.2B.
Takeda and Koneksa Health Announce Strategic Collaboration to Use Digital ...
CAMBRIDGE, Mass. & NEW YORK--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and Koneksa Health, Inc. (“Koneksa”), an early stage company focused on the integration of real world data into clinical research, ...